Ads
related to: vaso-occlusive sickle cell disease treatment- Treatment Journey
See the treatment journey
Step by step.
- Mechanism of Action Video
Watch an MOA video on the
official HCP website.
- About The Therapy
The science behind the disease
and this treatment option.
- Treatment Journey Video
See the treatment journey
video on the HCP website.
- Stay Informed
Sign up to receive updates
as they become available.
- Resources
Downloadable HCP brochure
and more professional resources.
- Treatment Journey
Search results
Results From The WOW.Com Content Network
The management of an acute event of vaso-occlusive crisis is the use of potent analgesics , rehydration with normal saline or Ringer's lactate, treatment of malaria (whether symptomatic or not) using artemisinin combination therapy, and the use of oxygen via face mask, especially for acute chest syndrome.
Crizanlizumab is indicated for the prevention of recurrent vaso occlusive crises in sickle cell disease patients aged 16 years and older. It can be given as an add on therapy to hydroxyurea/hydroxycarbamide (HU/HC) or as monotherapy in patients for whom HU/HC is inappropriate or inadequate.
In the US, exagamglogene autotemcel is indicated for the treatment of sickle cell disease in people aged 12 years and older with recurrent vaso-occlusive crises, and for the treatment of people with transfusion-dependent beta-thalassemia.
FDA approves cure for sickle cell disease, the first treatment to use CRISPR. Berkeley Lovelace Jr. and Marina Kopf. December 8, 2023 at 10:19 AM. The Food and Drug Administration on Friday...
The independent committee is helping the FDA think through how it should evaluate a treatment called exa-cel that could potentially cure people of sickle cell disease, a painful and deadly...
- Dick Vitale shares latest step in his journey with vocal cord canceraol.com
- Jane Fonda, 84, shares she is battling cancer and has started chemo treatmentsaol.com
- Olivia Munn reveals she had a hysterectomy last month as part of breast cancer treatmentaol.com
The FDA is reviewing a new drug for sickle cell disease that uses CRISPR to edit DNA. Black patients with the disease are excited and hopeful about the treatment.
Ads
related to: vaso-occlusive sickle cell disease treatment